Form 4 for GANX Gain Therapeutics, Inc.
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001415889-22-005798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-27 | 2022-05-25 | GANX | RICHMAN ERIC I | CEO, Dir | P - Purchase | $2.58 | +2,482 | 217.7K | +1% | +$6,404 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-05-25 | P | A | 2,482 | $2.58 | 217,729 | D | — | — |